KYMR
Price
$40.61
Change
+$0.32 (+0.79%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
2.63B
33 days until earnings call
SNDX
Price
$13.08
Change
+$0.08 (+0.62%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
1.12B
46 days until earnings call
Ad is loading...

KYMR vs SNDX

Header iconKYMR vs SNDX Comparison
Open Charts KYMR vs SNDXBanner chart's image
Kymera Therapeutics
Price$40.61
Change+$0.32 (+0.79%)
Volume$1.8K
Capitalization2.63B
Syndax Pharmaceuticals
Price$13.08
Change+$0.08 (+0.62%)
Volume$25.67K
Capitalization1.12B
KYMR vs SNDX Comparison Chart
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. SNDX commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and SNDX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (KYMR: $40.29 vs. SNDX: $13.00)
Brand notoriety: KYMR and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 151% vs. SNDX: 56%
Market capitalization -- KYMR: $2.63B vs. SNDX: $1.12B
KYMR [@Biotechnology] is valued at $2.63B. SNDX’s [@Biotechnology] market capitalization is $1.12B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, both KYMR and SNDX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 5 TA indicator(s) are bullish while SNDX’s TA Score has 4 bullish TA indicator(s).

  • KYMR’s TA Score: 5 bullish, 2 bearish.
  • SNDX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than SNDX.

Price Growth

KYMR (@Biotechnology) experienced а -0.57% price change this week, while SNDX (@Biotechnology) price change was -5.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.05%. For the same industry, the average monthly price growth was +3.04%, and the average quarterly price growth was -1.59%.

Reported Earning Dates

KYMR is expected to report earnings on May 01, 2025.

SNDX is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($2.63B) has a higher market cap than SNDX($1.12B). KYMR YTD gains are higher at: 0.149 vs. SNDX (-1.664). KYMR has higher annual earnings (EBITDA): -160.96M vs. SNDX (-296.86M). KYMR has more cash in the bank: 550M vs. SNDX (406M). SNDX has less debt than KYMR: SNDX (854K) vs KYMR (88.2M). KYMR has higher revenues than SNDX: KYMR (87.6M) vs SNDX (16M).
KYMRSNDXKYMR / SNDX
Capitalization2.63B1.12B236%
EBITDA-160.96M-296.86M54%
Gain YTD0.149-1.664-9%
P/E RatioN/AN/A-
Revenue87.6M16M548%
Total Cash550M406M135%
Total Debt88.2M854K10,328%
FUNDAMENTALS RATINGS
SNDX: Fundamental Ratings
SNDX
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
68
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYMRSNDX
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 5 days ago
84%
Momentum
ODDS (%)
Bullish Trend 5 days ago
81%
Bearish Trend 5 days ago
83%
MACD
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 5 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
81%
Bearish Trend 5 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
81%
Advances
ODDS (%)
Bullish Trend 16 days ago
85%
Bullish Trend 11 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 5 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
88%
N/A
Aroon
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
74%
View a ticker or compare two or three
Ad is loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY591.64-1.14
-0.19%
SPDR® S&P 500® ETF Trust
BTC.X99756.910000-747.585940
-0.74%
Bitcoin cryptocurrency
GME27.72-0.24
-0.86%
GameStop Corp
TSLA413.82-14.40
-3.36%
Tesla
AAPL228.26-9.61
-4.04%
Apple

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-7.51%
CCCC - KYMR
61%
Loosely correlated
-4.46%
XENE - KYMR
49%
Loosely correlated
-1.27%
CRSP - KYMR
49%
Loosely correlated
+3.23%
ERAS - KYMR
48%
Loosely correlated
-3.12%
ORIC - KYMR
48%
Loosely correlated
-7.64%
More

SNDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with ARVN. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then ARVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
+1.56%
ARVN - SNDX
46%
Loosely correlated
-0.85%
ABOS - SNDX
46%
Loosely correlated
-5.85%
KYMR - SNDX
43%
Loosely correlated
-7.51%
CELC - SNDX
41%
Loosely correlated
+0.18%
CRSP - SNDX
41%
Loosely correlated
+3.23%
More